Literature DB >> 11271792

Neutrophil disorders and their management.

R Lakshman1, A Finn.   

Abstract

Neutrophil disorders are an uncommon yet important cause of morbidity and mortality in infants and children. This article is an overview of these conditions, with emphasis on clinical recognition, rational investigation, and treatment. A comprehensive list of references is provided for further reading.

Entities:  

Mesh:

Year:  2001        PMID: 11271792      PMCID: PMC1731272          DOI: 10.1136/jcp.54.1.7

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  122 in total

Review 1.  Antimicrobial prophylaxis.

Authors:  J Smith; A Finn
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

2.  Mutations of the granulocyte-colony stimulating factor receptor in patients with severe congenital neutropenia are not required for transformation to acute myeloid leukaemia and may be a bystander phenomenon.

Authors:  T Bernard; R E Gale; J P Evans; D C Linch
Journal:  Br J Haematol       Date:  1998-04       Impact factor: 6.998

3.  Familial cyclical neutropenia.

Authors:  A A Morley; J P Carew; A G Baikie
Journal:  Br J Haematol       Date:  1967-09       Impact factor: 6.998

4.  Neutrophil antibody specificity in different types of childhood autoimmune neutropenia.

Authors:  M C Bruin; A E von dem Borne; R Y Tamminga; M Kleijer; L Buddelmeijer; M de Haas
Journal:  Blood       Date:  1999-09-01       Impact factor: 22.113

Review 5.  X-linked cardioskeletal myopathy and neutropenia (Barth syndrome)-MIM 302060.

Authors:  P G Barth; R J Wanders; P Vreken
Journal:  J Pediatr       Date:  1999-09       Impact factor: 4.406

6.  Rapid typing of the human Fc gamma receptor IIA polymorphism by polymerase chain reaction amplification with allele-specific primers.

Authors:  B K Flesch; F Bauer; J Neppert
Journal:  Transfusion       Date:  1998-02       Impact factor: 3.157

7.  Pyoderma gangrenosum in a child with congenital partial deficiency of leucocyte adherence glycoproteins.

Authors:  A J Bedlow; E G Davies; A L Moss; N Rebuck; A Finn; R A Marsden
Journal:  Br J Dermatol       Date:  1998-12       Impact factor: 9.302

8.  A novel leukocyte adhesion deficiency caused by expressed but nonfunctional beta2 integrins Mac-1 and LFA-1.

Authors:  N Hogg; M P Stewart; S L Scarth; R Newton; J M Shaw; S K Law; N Klein
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

9.  Deletion of a critical internalization domain in the G-CSFR in acute myelogenous leukemia preceded by severe congenital neutropenia.

Authors:  M G Hunter; B R Avalos
Journal:  Blood       Date:  1999-01-15       Impact factor: 22.113

10.  Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B.

Authors:  H Ozsahin; M von Planta; I Müller; H C Steinert; D Nadal; R Lauener; P Tuchschmid; U V Willi; M Ozsahin; N E Crompton; R A Seger
Journal:  Blood       Date:  1998-10-15       Impact factor: 22.113

View more
  36 in total

Review 1.  Neutrophils in the Tumor Microenvironment.

Authors:  Davalyn R Powell; Anna Huttenlocher
Journal:  Trends Immunol       Date:  2015-12-14       Impact factor: 16.687

2.  Staphylococcus aureus: an introduction.

Authors:  Ian A Myles; Sandip K Datta
Journal:  Semin Immunopathol       Date:  2012-01-27       Impact factor: 9.623

3.  Postmortem diagnosis of chronic granulomatous disease: how worthwhile is it?

Authors:  R Lakshman; S Bruce; D A Spencer; D Crawford; A Galloway; P N Cooper; D Barge; D Roos; T J Flood; M Abinun
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

Review 4.  Best practice in primary care pathology: review 7.

Authors:  W S A Smellie; J Forth; S R S Smart; M J Galloway; W Irving; D Bareford; P O Collinson; K G Kerr; G Summerfield; P J Carey; Rubin Minhas
Journal:  J Clin Pathol       Date:  2006-10-17       Impact factor: 3.411

5.  Kinesin-5 Blocker Monastrol Protects Against Bortezomib-Induced Peripheral Neurotoxicity.

Authors:  Ilja Bobylev; Dominik Peters; Maulik Vyas; Mohammed Barham; Ines Klein; Elke Pogge von Strandmann; Wolfram F Neiss; Helmar C Lehmann
Journal:  Neurotox Res       Date:  2017-06-13       Impact factor: 3.911

6.  Distinct regulation of the anterior and posterior myeloperoxidase expression by Etv2 and Gata1 during primitive Granulopoiesis in zebrafish.

Authors:  Nicole O Glenn; Jennifer A Schumacher; Hyon J Kim; Emma J Zhao; Jurate Skerniskyte; Saulius Sumanas
Journal:  Dev Biol       Date:  2014-06-20       Impact factor: 3.582

Review 7.  More friend than foe: the emerging role of neutrophils in tissue repair.

Authors:  Moritz Peiseler; Paul Kubes
Journal:  J Clin Invest       Date:  2019-06-17       Impact factor: 14.808

Review 8.  The Diverse Biological Functions of Neutrophils, Beyond the Defense Against Infections.

Authors:  Fan Yang; Chang Feng; Xiaodong Zhang; Jun Lu; Yong Zhao
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

Review 9.  Innate and adaptive immune responses against Staphylococcus aureus skin infections.

Authors:  Sheila Krishna; Lloyd S Miller
Journal:  Semin Immunopathol       Date:  2011-11-06       Impact factor: 9.623

Review 10.  The rise and rise of Staphylococcus aureus: laughing in the face of granulocytes.

Authors:  S Anwar; L R Prince; S J Foster; M K B Whyte; I Sabroe
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.